About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The group’s basic and clinical research activity, above all, surrounds the fields of inflammation and repair, respiratory insufficiency and tissue hypoxia, and these fields complement one another and are connected through the study of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, infections, transplants, pulmonary hypertension or sleep-related breathing disorders.
The group has an experimental research laboratory and a clinical research and clinical trial unit. It is made up of professionals from different specialties (pulmonologists, biologists, nurses, laboratory technicians, physiotherapists etc.). This multidisciplinary team provides an added value to the group and guarantees the existence of the critical mass necessary to carry out scientific projects.
Our group is a node that belongs to the CIBERES network (CIBER for respiratory diseases) and also works in collaboration with groups of the highest national and international prestige.
PMID: 35032736 Journal: RESPIRATORY MEDICINE Year: 2022 Reference: Respir Med. 2022 Feb;192:106736. doi: 10.1016/j.rmed.2022.106736. Epub 2022 Jan 6. Impact factor: 3.415 Publication type: Paper in international publication Authors: Calderazzo, Maria Adelaide, Pizzamiglio, Giovanna, Castillo-Corullon, Silvia, Alvarez-Fernandez, Antonio, Gartner, Silvia, Padoan, Rita, Carnovale, Vincenzo, Salvatore, Marco, Moya-Quiles, M feminine Rosa, Orenti, Annalisa et al. DOI: 10.1016/j.rmed.2022.106736
PMID: 33632708 Journal: GUT Year: 2022 Reference: Gut. 2022 Feb;71(2):415-423. doi: 10.1136/gutjnl-2020-323729. Epub 2021 Feb 25. Impact factor: 23.059 Publication type: Paper in international publication Authors: Fromme, Malin, Schneider, Carolin V, Pereira, Vitor, Hamesch, Karim, Pons, Monica, Reichert, Matthias C, Benini, Federica, Ellis, Paul, H Thorhauge, Katrine, Mandorfer, Mattias et al. DOI: 10.1136/gutjnl-2020-323729
PMID: 33675523 Journal: ADVANCES IN THERAPY Year: 2021 Reference: Adv Ther. 2021 Apr;38(4):1860-1875. doi: 10.1007/s12325-021-01625-w. Epub 2021 Mar 6. Impact factor: 3.847 Publication type: Paper in international publication Authors: Martinez Menaca, Amaya, Blanco Vich, Isabel, Lopez Meseguer, Manuel, Lopez Reyes, Raquel, Bedate Diaz, Pedro, Elias Hernandez, Teresa, Fernandez-Cuesta Penafiel, Ines, Fernandez, Gonzalo, Alvez Liste, Ana, Escribano Subias, Pilar et al. DOI: 10.1007/s12325-021-01625-w
PMID: 33367993 Journal: Canadian Journal of Anesthesia-Journal canadien d anesthesie Year: 2021 Reference: Can J Anaesth. 2021 Mar;68(3):434-435. doi: 10.1007/s12630-020-01887-y. Epub 2020 Dec 24. Impact factor: 5.063 Publication type: Letter or abstract Authors: Loor, Karina, Alvarez, Antonio, Felipe Montiel, Almudena, Ferrer, Ricard, Roca, Oriol, Garcia-de-Acilu, Marina, Clofent, David, Landivar, Jose Cardoso, Polverino, Eva, Culebras Amigo, Mario et al. DOI: 10.1007/s12630-020-01887-y
PMID: 33614773 Journal: ERJ open research Year: 2021 Reference: ERJ Open Res. 2021 Feb 15;7(1). pii: 00807-2020. doi: 10.1183/23120541.00807-2020. eCollection 2021 Jan. Impact factor: 0 Publication type: Letter whit IF Authors: Posthumus, Annette, Ruddy, Thomas, Goeminne, Pieter, Lloyd, Ernie, Alan, Timothy, Altenburg, Josje, Crossley, Barbara, Blasi, Francesco, Chalmers, James, Berg, Tove et al. DOI: 10.1183/23120541.00807-2020
PMID: 33583300 Journal: Expert Review of Respiratory Medicine Year: 2021 Reference: Expert Rev Respir Med. 2021 May;15(5):623-634. doi: 10.1080/17476348.2021.1886084. Epub 2021 Feb 17. Impact factor: 3.772 Publication type: Paper in international publication Authors: Clofent, David, Alvarez, Antonio, Traversi, Letizia, Culebras, Mario, Loor, Karina, Polverino, Eva et al. DOI: 10.1080/17476348.2021.1886084
PMID: 29326319 Journal: EUROPEAN RESPIRATORY JOURNAL Year: 2018 Reference: Eur Respir J. 2018 Jan 11;51(1). pii: 51/1/1701937. doi: 10.1183/13993003.01937-2017. Print 2018 Jan. Impact factor: 12.242 Publication type: Editorail in international publication Authors: Chalmers, James D, Ringshausen, Felix C, Harris, Bridget, Elborn, J Stuart, Posthumus, Annette, Haworth, Charles S, Pilkington, Nicola, Polverino, Eva, Ruddy, Thomas, Aliberti, Stefano et al. DOI: 10.1183/13993003.01937-2017
PMID: 29301926 Journal: EUROPEAN RESPIRATORY JOURNAL Year: 2018 Reference: Eur Respir J. 2018 Jan 4;51(1). pii: 51/1/1702033. doi: 10.1183/13993003.02033-2017. Print 2018 Jan. Impact factor: 12.242 Publication type: Letter or abstract Authors: Chalmers, James D, Polverino, Eva et al. DOI: 10.1183/13993003.02033-2017
PMID: 28811074 Journal: Transplantation Reviews Year: 2018 Reference: Transplant Rev (Orlando). 2018 Jan;32(1):36-57. doi: 10.1016/j.trre.2017.07.001. Epub 2017 Jul 26. Impact factor: 2.364 Publication type: Clinical guide Authors: Martin-Davila, P, Montejo, M, Moreno, A, Oliver, A, Pascual, A, Perez-Nadales, E, Roman-Broto, A, San-Juan, R, Seron, D, Sole-Jover, A et al. DOI: 10.1016/j.trre.2017.07.001
The EXPOSIM project will investigate the impact of environmental stressors such as pollution, noise and aeroallergens on immune-mediated diseases.
This recognition highlights both his career and the level of respiratory research in Spain.
The ERS Awards recognize outstanding members for their exceptional contributions in the field of respiratory medicine.
EXIMIOUS (Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome), un projecte finançat per la Unió Europea que engloba 15 organitzacions de 7 països europeus.
EXIMIOUS té com a objectiu estudiar l’exposoma, és a dir, l’exposició a factors ambientals al llarg de la vida, per entendre la seva relació amb les malalties immunomediades, com ara les malalties autoimmunes o les al·lèrgies. Des del VHIR està liderat per la Dra. M Jesús Cruz i el seu equip de Pneumologia.
